Main Logo
+17162654855
[email protected]

Growth Trajectories in Japan Eye Drops Industry: Industry Outlook to 2034

Japan Eye Drops Industry by Product (Devices, Drugs), by Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, Other Diseases), by Japan Forecast 2026-2034

Base Year: 2025
197 Pages
Main Logo

Growth Trajectories in Japan Eye Drops Industry: Industry Outlook to 2034

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of Japan Eye Drops Industry

Higher Coverage
Lower Coverage
No Coverage

Japan Eye Drops Industry REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 12.83% from 2020-2034
Segmentation
    • By Product
      • Devices
        • Surgical Devices
          • Intraocular Lenses
          • Ophthalmic Lasers
          • Other Surgical Devices
        • Diagnostic Devices
      • Drugs
        • Glaucoma Drugs
        • Retinal Disorder Drugs
        • Dry Eye Drugs
        • Allergic Conjunctivitis and Inflammation Drugs
        • Other Drugs
    • By Disease
      • Glaucoma
      • Cataract
      • Age-Related Macular Degeneration
      • Inflammatory Diseases
      • Refractive Disorders
      • Other Diseases
  • By Geography
    • Japan

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Product
      • 5.1.1. Devices
        • 5.1.1.1. Surgical Devices
          • 5.1.1.1.1. Intraocular Lenses
          • 5.1.1.1.2. Ophthalmic Lasers
          • 5.1.1.1.3. Other Surgical Devices
        • 5.1.1.2. Diagnostic Devices
      • 5.1.2. Drugs
        • 5.1.2.1. Glaucoma Drugs
        • 5.1.2.2. Retinal Disorder Drugs
        • 5.1.2.3. Dry Eye Drugs
        • 5.1.2.4. Allergic Conjunctivitis and Inflammation Drugs
        • 5.1.2.5. Other Drugs
    • 5.2. Market Analysis, Insights and Forecast - by Disease
      • 5.2.1. Glaucoma
      • 5.2.2. Cataract
      • 5.2.3. Age-Related Macular Degeneration
      • 5.2.4. Inflammatory Diseases
      • 5.2.5. Refractive Disorders
      • 5.2.6. Other Diseases
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. Japan
  6. 6. Japan Eye Drops Industry Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Product
      • 6.1.1. Devices
        • 6.1.1.1. Surgical Devices
          • 6.1.1.1.1. Intraocular Lenses
          • 6.1.1.1.2. Ophthalmic Lasers
          • 6.1.1.1.3. Other Surgical Devices
        • 6.1.1.2. Diagnostic Devices
      • 6.1.2. Drugs
        • 6.1.2.1. Glaucoma Drugs
        • 6.1.2.2. Retinal Disorder Drugs
        • 6.1.2.3. Dry Eye Drugs
        • 6.1.2.4. Allergic Conjunctivitis and Inflammation Drugs
        • 6.1.2.5. Other Drugs
    • 6.2. Market Analysis, Insights and Forecast - by Disease
      • 6.2.1. Glaucoma
      • 6.2.2. Cataract
      • 6.2.3. Age-Related Macular Degeneration
      • 6.2.4. Inflammatory Diseases
      • 6.2.5. Refractive Disorders
      • 6.2.6. Other Diseases
  7. 7. Competitive Analysis
      • 7.1. Company Profiles
        • 7.1.1 Ziemer Group AG
          • 7.1.1.1. Company Overview
          • 7.1.1.2. Products
          • 7.1.1.3. Company Financials
          • 7.1.1.4. SWOT Analysis
        • 7.1.2 Carl Zeiss Meditec AG
          • 7.1.2.1. Company Overview
          • 7.1.2.2. Products
          • 7.1.2.3. Company Financials
          • 7.1.2.4. SWOT Analysis
        • 7.1.3 Essilor International SA
          • 7.1.3.1. Company Overview
          • 7.1.3.2. Products
          • 7.1.3.3. Company Financials
          • 7.1.3.4. SWOT Analysis
        • 7.1.4 Nidek Co Ltd
          • 7.1.4.1. Company Overview
          • 7.1.4.2. Products
          • 7.1.4.3. Company Financials
          • 7.1.4.4. SWOT Analysis
        • 7.1.5 Johnson & Johnson
          • 7.1.5.1. Company Overview
          • 7.1.5.2. Products
          • 7.1.5.3. Company Financials
          • 7.1.5.4. SWOT Analysis
        • 7.1.6 Topcon Corporation
          • 7.1.6.1. Company Overview
          • 7.1.6.2. Products
          • 7.1.6.3. Company Financials
          • 7.1.6.4. SWOT Analysis
        • 7.1.7 Alcon Inc
          • 7.1.7.1. Company Overview
          • 7.1.7.2. Products
          • 7.1.7.3. Company Financials
          • 7.1.7.4. SWOT Analysis
        • 7.1.8 Bausch Health Companies Inc
          • 7.1.8.1. Company Overview
          • 7.1.8.2. Products
          • 7.1.8.3. Company Financials
          • 7.1.8.4. SWOT Analysis
      • 7.2. Market Entropy
        • 7.2.1 Company's Key Areas Served
        • 7.2.2 Recent Developments
      • 7.3. Company Market Share Analysis 2025
        • 7.3.1 Top 5 Companies Market Share Analysis
        • 7.3.2 Top 3 Companies Market Share Analysis
    • 7.4. List of Potential Customers
  8. 8. Research Methodology

    List of Figures

    1. Figure 1: Japan Eye Drops Industry Revenue Breakdown (billion, %) by Product 2025 & 2033
    2. Figure 2: Japan Eye Drops Industry Share (%) by Company 2025

    List of Tables

    1. Table 1: Japan Eye Drops Industry Revenue billion Forecast, by Product 2020 & 2033
    2. Table 2: Japan Eye Drops Industry Volume K Unit Forecast, by Product 2020 & 2033
    3. Table 3: Japan Eye Drops Industry Revenue billion Forecast, by Disease 2020 & 2033
    4. Table 4: Japan Eye Drops Industry Volume K Unit Forecast, by Disease 2020 & 2033
    5. Table 5: Japan Eye Drops Industry Revenue billion Forecast, by Region 2020 & 2033
    6. Table 6: Japan Eye Drops Industry Volume K Unit Forecast, by Region 2020 & 2033
    7. Table 7: Japan Eye Drops Industry Revenue billion Forecast, by Product 2020 & 2033
    8. Table 8: Japan Eye Drops Industry Volume K Unit Forecast, by Product 2020 & 2033
    9. Table 9: Japan Eye Drops Industry Revenue billion Forecast, by Disease 2020 & 2033
    10. Table 10: Japan Eye Drops Industry Volume K Unit Forecast, by Disease 2020 & 2033
    11. Table 11: Japan Eye Drops Industry Revenue billion Forecast, by Country 2020 & 2033
    12. Table 12: Japan Eye Drops Industry Volume K Unit Forecast, by Country 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the Japan Eye Drops Industry?

    The projected CAGR is approximately 12.83%.

    2. Which companies are prominent players in the Japan Eye Drops Industry?

    Key companies in the market include Ziemer Group AG, Carl Zeiss Meditec AG, Essilor International SA, Nidek Co Ltd, Johnson & Johnson, Topcon Corporation, Alcon Inc, Bausch Health Companies Inc.

    3. What are the main segments of the Japan Eye Drops Industry?

    The market segments include Product, Disease.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 9.78 billion as of 2022.

    5. What are some drivers contributing to market growth?

    Demographic Shift and Impact of Prevalence of Eye Disease; Technological Advancements in the Field of Ophthalmology.

    6. What are the notable trends driving market growth?

    Glaucoma Segment is Expected to Show Better Growth in the Forecast Years.

    7. Are there any restraints impacting market growth?

    Higher Cost of the Ophthalmic Devices and Treatment.

    8. Can you provide examples of recent developments in the market?

    In July 2022, NIDEK TECHNOLOGIES S.R.L., a subsidiary of NIDEK CO., LTD. acquired 90% of the shares of NIDEK MEDICAL S.R.L., a sales and service company of ophthalmic devices.

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in billion and volume, measured in K Unit.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "Japan Eye Drops Industry," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the Japan Eye Drops Industry report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the Japan Eye Drops Industry?

    To stay informed about further developments, trends, and reports in the Japan Eye Drops Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.